Placebo-controlled trials in osteoporosis--proceeding with caution.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20879887.
- Also identified by DOI 10.1056/NEJMsb1002227 and PMC identifier 3901575.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article presents one viewpoint on the issues surrounding placebo-controlled trials in osteoporosis. The other Sounding Board article in this issue presents an opposing view. At NEJM.org, in a related interactive feature, the authors of each article give their Point of View about the other article. At NEJM.org, readers can participate in forming community opinion by choosing one of the viewpoints and, if they like, providing their reasons.
Medical subject headings
- Fractures, Bone
- Osteoporosis, Postmenopausal
- Placebos
- Randomized Controlled Trials as Topic